Chronic Kidney Disease and Cardiovascular Disease Risk Assessment

July 12, 2022 updated by: Mark D. Baldwin, Pacific Northwest University of Health Sciences

Chronic Kidney Disease and Cardiovascular Disease Risk Assessment in Yakima County

This study will investigate chronic kidney disease (CKD) and cardiovascular disease (CVD) risk factors in a sample population of Hispanics/Latinos and Caucasians in Yakima county that are rural dwelling. This investigation is intended to provide information on the impact rural geographical location and social determinants of health (SDOH) have on CKD and CVD risk factors.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

Yakima County has a large hispanic farmworker population. The peak work times are between May and September. There is a growing body of research that shows the risk of agricultural workers in work environments with extreme heat.

The purpose of this pilot study is to look at incidence of non-diagnosed chronic kidney disease within Yakima County to inform future studies to examine other factors and unique bio-markers that may help in the early diagnosis of heat related injuries in agricultural workers.

Study Type

Observational

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All adults of between the ages of 18 and 75 who do not meet the exclusion criteria and wish to undergo screening for kidney disease and diabetes.

Description

Inclusion Criteria:

  • Between the ages of 18 and 75

Exclusion Criteria:

  • Active malignancy
  • Currently pregnant
  • End stage renal disease requiring dialysis
  • Current active treatment for diabetes mellitus
  • Current care by a nephrologist for chronic kidney disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of undiagnosed chronic kidney disease in farmworkers in Yakima County, WA
Time Frame: At the time of screening
Finger stick and urinalysis will be done at the time of screening
At the time of screening

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of undiagnosed diabetes mellitus in farmworkers in Yakima County, WA
Time Frame: At the time of screening
Finger stick will be done at the time of screening
At the time of screening
Incidence of undiagnosed hypertension in farmworkers in Yakima, County, WA
Time Frame: At the time of screening
Measurement of blood pressure
At the time of screening

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pacific Northwest University of Health Sciences

Investigators

  • Principal Investigator: Mark D Baldwin, DO, Pacific Northwest University of Health Science

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

February 5, 2020

Study Completion (Actual)

February 5, 2020

Study Registration Dates

First Submitted

June 4, 2019

First Submitted That Met QC Criteria

June 4, 2019

First Posted (Actual)

June 5, 2019

Study Record Updates

Last Update Posted (Actual)

July 14, 2022

Last Update Submitted That Met QC Criteria

July 12, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-004

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Hemoglobin A1C

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe